Richard Yu, CEO of Huawei's consumer business, said Huawei's own operating system for smartphones and laptops could be ready for use in China by fall this year.Technologyread more
U.S. stock index futures were lower Thursday morning, as market participants continue to monitor an intensifying trade war between the world's two largest economies.US Marketsread more
British Prime Minister Theresa May could announce her resignation in the next few days, according to U.K. media reports, as she faces increasing pressure from members of her...Europe Politicsread more
Shares of Chinese telecommunications heavyweight Huawei's suppliers took a hit on Thursday amid the ongoing fallout surrounding the Chinese telecommunications giant.Asia Marketsread more
Lawmakers, lobbyists and CEOs in the U.S. are looking to trying to pick out the best parts of the EU's privacy law called GDPR – and ditch what they see as the worst.Technologyread more
Indian Prime Minister Modi is on course to return to power for a second term after his party reportedly won big at the parliamentary elections.Electionsread more
The embattled German lender saw its share price hit a record low Monday, down nearly 5% since the start of the year.Banksread more
Among the many ways Trump has shattered White House norms, his impulsive public communications rank among the most consequential. By inspiring investors or spooking them, his...Politicsread more
Political experts believe the vote could give more insight into national politics in each member state, rather than on the future of the EU itself.Europe Politicsread more
A federal judge in New York City on Wednesday said Deutsche Bank and Capital One can turn over financial documents related to President Donald Trump and his businesses in...Politicsread more
China accounted for 40% to 60% of the global increase in trichlorofluoromethane, or CFC-11, emissions between 2014 and 2017, a study found.Scienceread more
Health care led all sectors in Q3 as investors rotated away from some of the high-flying tech names and into more defensive plays.
The sector gained 14.04% -- its best quarterly performance since Q1 2013 -- and some investors believe the trade is just starting to heat up.
Virtus Investment Partners' Joe Terranova owns and continues to like it. The pharma giant has nearly doubled in value over the past two years, but Terranova thinks strength in the company's medical devices division will continue to drive the stock higher.
"It's a very diversified company, but the medical devices division reported very strong results on the aortic valve therapeutics that they're developing right now, so I'm staying with it," he said on the "Halftime Report."
The Illinois-based company hit a new all-time high on Friday, bringing its total gain for the year to just under 30%.
In the medical devices space Terranova also likes Edwards Lifesciences. "Take a look at that chart. It's really moving and it has great fundamentals." The stock currently trades at 31.75X next year's earnings, and it has soared 43.8% this year through Tuesday's close.
Health care as a whole has rallied, but not all individual names have posted stellar gains. HPM Partners' Jim Lebenthal likes Allergan, which he owns, for that very reason.
"Health care has taken over leadership in the last few months, but some of the early risers in that trend have kind of sputtered recently...Allergan is one that sputtered for a few weeks and now I'm seeing it catch a bid. It's still ridiculously undervalued, and I see it going higher from here, " he said on Tuesday's "Halftime Report." The Dublin-based company trades at 11.59X next year's earnings and yields 1.49%.
Q3 earnings season kicks off next week and Street expectations are high.
Nuveen managing director Stephanie Link believes we'll continue to see strenth in the health care space. "I went to a bunch of conferences over the past couple of weeks in health care and they sound dynamite across the board. I still think you're going to see strength there," she said on Tuesday's "Halftime Report."